HomeCDTX • NASDAQ
Follow
Cidara Therapeutics Inc
Previous close
$0.84
Day range
$0.85 - $0.96
Year range
$0.59 - $1.48
Market cap
83.58M USD
Avg Volume
524.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 12.72M | -68.79% |
Operating expense | 3.56M | -38.48% |
Net income | -8.17M | -154.56% |
Net profit margin | -64.26 | -274.81% |
Earnings per share | -0.09 | -152.94% |
EBITDA | -8.53M | -157.04% |
Effective tax rate | -2.90% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 48.67M | -8.30% |
Total assets | 63.47M | -5.07% |
Total liabilities | 55.43M | -4.09% |
Total equity | 8.04M | — |
Shares outstanding | 90.43M | — |
Price to book | 9.36 | — |
Return on assets | -32.54% | — |
Return on capital | -132.22% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -8.17M | -154.56% |
Cash from operations | -1.63M | -105.84% |
Cash from investing | -126.00K | -1,300.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.76M | -106.27% |
Free cash flow | 2.23M | -84.61% |
About
Founded
2012
Headquarters
Website
Employees
73